【摘要】 乙型肝炎病毒(HBV)感染是肝脏疾病进展甚至癌变的重要病因。HBV的完整生命周期依赖于宿主细胞，因此囊括了抑制病毒进入、破坏病毒核酸稳定性和增强宿主对HBV免疫反应等的靶向宿主细胞抗病毒(host-targeting antiviral, HTA)治疗方案颇有前景。本文综述了通过靶向作用于宿主和宿主因子，从而达到抗病毒作用的药物研发进展，以期为后续抗病毒研究和临床治疗提供选择手段。更多还原

【Abstract】 Chronic hepatitis B virus infection is an important factor in the progression of liver disease and hepatocellular carcinoma. The complete life cycle of hepatitis B virus is dependent on the host cell, which makes host-targeting antiviral(HTA) treatment options promising. The HTA includes inhibition of virus entry, destabilization of viral nucleic acids and enhancement of host immune response to HBV infection. This paper reviewed the development of medicines that target hosts and host factors in order to achieve the goal of hepatitis B virus suppression, with a view to providing a reference for subsequent antiviral research and clinical treatment.更多还原